(HealthDay News) — The US Supreme Court said Tuesday that it will not hear Johnson & Johnson’s appeal over a $2 billion ruling in favor of women who said they developed ovarian cancer from using the company’s talc products.
The nation’s top court did not say why it rejected Johnson & Johnson’s appeal, the Associated Press reported.
A state court in Missouri initially awarded $4.7 billion to 22 women, but a state appeals court cut that to $2 billion and eliminated two of the plaintiffs.
Continue Reading
Johnson & Johnson claimed it was not treated fairly because it faced one trial involving 22 plaintiffs from 12 states and different backgrounds, the AP reported.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.